CASK ('calcium/calmodulin-dependent serine protein kinase'), also known in Drosophila as 'Caki' or 'Camguk/ CMG', and in C. elegans as 'Lin-2', is thought to play an important role in cell-cell junction formation and at synapses in particular. To understand the role of CASK in synapse formation and function, we functionally and morphologically analyzed Drosophila embryonic and larval glutamatergic neuromuscular junctions (NMJs) after pan-cellular and tissue-specific manipulation of CASK expression. Our results show that Drosophila CASK is associated with both pre and postsynaptic membranes. Loss of presynaptic CASK led to less evoked synaptic transmission, fewer spontaneous synaptic events, and reduced synaptic vesicle cycling. These changes were accompanied by a reduction in the number of synapses but no change in overall NMJ size. Loss of postsynaptic CASK, on the other hand, caused reduced spontaneous synaptic current amplitudes and smaller glutamategated currents. These changes were accompanied by loss of postsynaptic glutamate receptors, but the receptor loss was subtype-specific: Only receptors containing GluRIIA subunits were lost in CASK mutants. Receptors containing GluRIIB were unaffected.
Introduction
CASK ('calcium/calmodulin-dependent serine protein kinase') was originally identified in yeast two hybrid screens for cytoplasmic proteins that interact with the synaptic cell adhesion protein neurexin (Hata et al., 1996) . CASK was named based on a large N-terminal serine/threonine kinase domain and strong similarity to calmodulindependent protein kinases, but was assumed to be catalytically inactive for several years, during which time studies focused primarily on CASK's potential role as a scaffolding protein. Indeed, CASK contains L27, PDZ, SH3, Hook, and (inactive) guanylate kinase domains known to be important for cell-cell junction organization, and CASK interacts with a variety of cell junction and membrane proteins besides neurexin, including Mint-1, Velis, syndecans, SynCAM, protein 4.1, calcium channels, potassium channels, and calcium pumps (Hsueh, 2006; Mukherjee et al., 2008) . Recently, however, it was shown that CASK exhibits magnesium-independent kinase activity and phosphorylates neurexin (Mukherjee et al., 2008) . CASK may also interact with transcription factors to regulate gene expression (Hsueh et al., 2000) .
What role might CASK's molecular functions play in synapses? Human CASK has been linked to X-linked optic atrophy, brain malformation, and mental retardation (Dimitratos et al., 1998; Froyen et al., 2007; Najm et al., 2008) . CASK knockout mice die shortly after birth, and cultured CASK-deficient neurons show changes in spine formation and synaptic function (Atasoy et al., 2007; Chao et al., 2008) . But it's not yet clear whether CASK promotes or suppresses synaptic function, or whether physiological phenotypes are attributable to alterations in synapse development. For example, miniature synaptic current frequency in cultured CASK KO neurons is increased for glutamatergic synapses but reduced for GABAergic synapses (Atasoy et al., 2007) . Neuroligin levels in CASK KO mice are increased, while Mint, Veli, and neurexin levels are decreased (Atasoy et al., 2007) .
The C. elegans CASK ortholog Lin-2 is important for vulval development (Horvitz and Sulston, 1980; Hoskins et al., 1996) , probably due to a role in membrane protein organization (Kaech et al., 1998) , but Lin-2's role at synapses has not to our knowledge been reported.
The Drosophila genome contains a single CASK-like gene, previously referred to by several names, including 'Caki', 'Camguk', 'CMG', 'DCASK', and 'DLin-2'. As in mammals, Drosophila CASK is expressed most highly in the nervous system (Dimitratos et al., 1997; Hata et al., 1996; Lopes et al., 2001; Martin and Ollo, 1996) . Recently, it was shown that the Drosophila CASK locus appears to encode two major protein isoforms, called 'CASK-beta' and 'CASK-alpha'. CASK-beta is predicted to be structurally homologous to mammalian CASK, but CASK-alpha is more similar to vertebrate MPP1 (Slawson et al., 2011) .
Drosophila CASK null mutants are viable, with alterations in synaptic transmission, visual system function, locomotor activity, and courtship behavior (Lu et al., 2003; Martin and Ollo, 1996; Slawson et al., 2011; Sun et al., 2009; Zordan et al., 2005) . However, some of the previously reported courtship and locomotory phenotypes may be due to loss of other genes besides CASK, or a subset of CASK isoforms, as isoform-specific mutations do not show the same phenotype as large deletions that remove the entire gene region (Slawson et al., 2011) . Drosophila CASK also modulates CAMKII activity and potassium current size (Hodge et al., 2006; Lu et al., 2003; Marble et al., 2005) .
What role does Drosophila CASK play in synapses? Electrophysiological recordings from adult indirect flight muscles and larval body wall muscles show that Drosophila CASK mutants have large reductions in evoked glutamatergic synaptic transmission, with shorter transmission latencies, and reduced FM1-43 dye uptake, but larger and more frequent miniature postsynaptic potentials (Sun et al., 2009; Zordan et al., 2005) . The discrepancies between pre and postsynaptic assays suggest that CASK may play divergent pre and postsynaptic roles. However, these roles remain relatively undefined.
Here, we show that CASK is present both pre and postsynaptically in Drosophila embryonic/larval NMJs, and differentiate for the first time the functional and developmental roles played by pre and postsynaptic CASK. In particular, we focus on the novel finding that loss of CASK leads to subunit-specific loss of postsynaptic glutamate receptors. We also describe for the first time the phenotype of Drosophila CASK mutant embryos, and directly compare these phenotypes to larval mutant phenotypes to show that CASK mutant phenotypes arise early in synapse development.
Results
Drosophila embryonic/larval neuromuscular junctions (NMJs) are relatively well-characterized and accessible in situ throughout development for a variety of techniques. We developed and affinity purified new anti-Drosophila CASK polyclonal antibodies and used them to stain embryonic and larval NMJs. As shown in Fig. 1 , anti-CASK immunoreactivity was highly enriched at NMJs, where it was visible in both presynaptic motor terminals and postsynaptic muscle. This staining was specific for CASK, as immunoreactivity was reduced to background levels in X-307/X-313 null mutants (Fig. 1A, B) . Anti-CASK immunoreactivity in larval NMJs was associated with both presynaptic terminals and muscle subsynaptic reticulum (SSR) surrounding presynaptic motor terminals. To confirm that CASK was present in both pre and postsynaptic tissues, we knocked down CASK using tissue-specific expression of CASK RNAi, and quantified anti-CASK immunoreactivity in the NMJ. In support of the idea that CASK is abundant postsynaptically, total anti-CASK immunoreactivity in larval NMJs was reduced approximately one-third after muscle-specific expression of CASK RNAi (Fig. 1A, C) . The same RNAi transgene expressed presynaptically reduced anti-CASK immunoreactivity by approximately one-fifth (Fig. 1A, C) . Anti-CASK immunoreactivity was not visible in the center of presynaptic terminals, even after musclespecific expression of CASK RNAi (Fig. 1C) .
To better understand the functional and developmental role of Drosophila CASK, we used voltage-clamp recordings from larval ( Fig. 2A-F) and embryonic ( Fig. 2G-M) NMJs. As shown in figure panels 2A and 2C, evoked excitatory junction current (EJC) amplitudes were significantly decreased in CASK mutant wandering third instar NMJs, compared to controls. Drosophila CASK is therefore required for maximal synaptic transmission in larval NMJs.
CASK could support synaptic transmission by regulating NMJ function or development. Larval NMJs undergo significant expansion and addition of new synapses during post-embryonic development. Thus, the loss of synaptic transmission in larval CASK mutants could be due to developmental abnormalities that have accumulated during altered larval NMJ growth. If so, we would expect EJCs recorded from CASK mutant NMJs in larvae (~120 h AEL) to be more dramatically reduced than EJCs recorded from CASK mutant NMJs in embryos (~22 h AEL). To test whether this was so, we performed patch clamp recordings from embryonic NMJs. Specifically, we recorded from muscle 6 -the same muscles we recorded from in larvae. As shown in figure panels 2 G and 2 J, embryonic CASK mutant NMJs showed an even larger reduction in EJC amplitude than did larval CASK mutant NMJs (56% vs. 23%, respectively).
Reduced EJC amplitudes could be due to presynaptic defects (reduced neurotransmitter release), postsynaptic defects (reduced postsynaptic glutamate receptor abundance or conductance), or both pre and postsynaptic defects. To help differentiate these possibilities, we recorded and analyzed spontaneous excitatory junction currents (sEJCs). In both larvae (Fig. 2B, D) and embryos (Fig. 2H, K) , sEJC frequency was significantly reduced. Embryonic CASK mutant sEJC frequency was reduced more than larval CASK mutant sEJC frequency (46% vs. 26%, respectively). sEJC amplitudes were also reduced in both Fig. 1 . CASK immunoreactivity in Drosophila larval muscle 6/7 NMJs. A: Anti-CASK immunoreactivity in control NMJs, CASK null mutants (X-307/X-313), and after expression of post and presynaptic RNAi (N = 3-11). B: Representative images of ventral longitudinal muscle 6/7 NMJs, showing immunoreactivity for the neuronal membrane marker anti-HRP (green) and anti-CASK (magenta), in control animals (top 3 panels) and CASK null mutants (bottom 3 panels). C: As in B, but for control animals (left 3 panels), after expression of postsynaptic CASK RNAi (middle 3 panels), and after expression of presynaptic CASK RNAi (right 3 panels). larval ( Fig. 2B , E, F) and embryonic (Fig. 2H , L) NMJs. CASK mutant sEJC amplitudes were slightly more reduced in embryos (36% reduction in embryos; 24% reduction in larvae).
To confirm that CASK mutants have defects in postsynaptic glutamate receptor function, we pressure ejected glutamate directly onto embryonic NMJs, where postsynaptic glutamate receptors are not yet buried in dense folds of SSR and therefore accurate measures of postsynaptic receptor abundance can be most readily performed. As expected, glutamate receptor currents in CASK mutant embryonic NMJs were significantly reduced (Fig. 2I, M) , and this reduction was very similar to the reductions observed in CASK mutant sEJC amplitudes (39% vs. 36%).
Presumably, the presynaptic defects we measured were caused by loss of presynaptic CASK, and the postsynaptic defects we measured were caused by loss of postsynaptic CASK. To test this explicitly, we utilized tissue-specific expression of CASK RNAi (Fig. 3) . As expected, presynaptic expression of CASK RNAi led to phenotypes associated with deficits in presynaptic function. Specifically, presynaptic (neuronal) CASK RNAi caused significant reductions in EJC amplitude (Fig. 3A , C) and sEJC frequency (Fig. 3B, D) , without any change in sEJC amplitude (Fig. 3B, E) . In contrast, postsynaptic (muscle) expression of CASK RNAi caused significant reductions in EJC amplitude (Fig. 3A , C) and sEJC amplitude (Fig. 3B, E ), but no change in sEJC frequency (Fig. 3B, D) .
To confirm and further explore these synaptic defects, we performed several types of functional and immunohistochemical analyses. First, we used FM1-43 dye loading and unloading to test whether CASK mutants have alterations in synaptic vesicle cycling. Results from these experiments are shown in Fig. 4 . As shown (Fig. 4A ), presynaptic motor terminals in both control and CASK mutants could be readily loaded with 10 μM FM1-43 in high potassium (90 mM) saline. However, CASK mutant terminals showed significantly lower FM1-43 loading rates (Fig. 4A , B) and unloading rates (Fig. 4C, D ), compared to controls. As a result, CASK mutant terminals showed relatively little change in FM1-43 fluorescence, compared to control terminals (Fig. 4E) . By correcting for the lesser amount of FM1-43 loaded per unit time in CASK mutants, the total fraction of FM1-43 fluorescence released per unit time could be calculated (Fig. 4F ). As shown (Fig. 4F ), CASK mutant terminals showed FM1-43 release deficits of approximately 25% after a minimum of 30 s in high potassium. These changes are similar in magnitude to the change in larval sEJC frequency that we measured electrophysiologically (Fig. 2) .
Drosophila NMJs contain multiple boutons. Each bouton has multiple synapses, and each synapse has a pool of cycling vesicles. Reduced FM1-43 loading and unloading in CASK mutants could reflect changes in vesicle cycling rates or simply a reduction in the total number of cycling vesicles due to a change in the number of synapses within each bouton. To address this, we checked to see whether CASK mutant NMJs and control NMJs had similar sizes and numbers of synapses. As shown in Fig. 5 , loss of CASK did not affect NMJ growth. The total NMJ area and number of boutons were unchanged in CASK mutants, compared to controls (Fig. 5A, C) . In contrast, the number of synapses per bouton, and thus the synapse density, was significantly reduced in CASK mutants compared to controls (Fig. 5B, C) . This result was confirmed using antibodies against bruchpilot, a CAST/ELKS/ERC homolog in presynaptic active zones Wagh et al., 2006) , as well as antibodies against GluRIIC, an essential postsynaptic glutamate receptor subunit in Drosophila embryonic & larval NMJs (Marrus et al., 2004) . The reduction in CASK mutant synapse number (~26%, depending on antibody used) was similar to the reductions in larval sEJC frequency and FM1-43 loading & unloading that we measured (26% and 25%, respectively). The size of individual presynaptic active zones did not appear to be altered in CASK mutants (Fig. 5D, E) .
CASK has long been assumed to play a role in presynaptic function, and our data support this idea. However, several lines of evidence presented here suggest that CASK also plays a postsynaptic role in Drosophila NMJs: 1) Drosophila CASK immunoreactivity was present both pre and postsynaptically (Fig. 1) . 2) Drosophila CASK mutants showed reductions in sEJC amplitudes (Figs. 2, 3 ) and GluR current size (Fig. 2M) , which are both diagnostic of reduced postsynaptic receptor function. 3) Finally, and most convincingly, reductions in sEJC amplitude were phenocopied by postsynaptic, but not presynaptic, expression of CASK RNAi (Fig. 3) . In the next series of experiments, we explored CASK's postsynaptic role.
Drosophila embryonic/larval NMJs contain two molecularly, biophysically, pharmacologically, developmentally, and spatially distinct subtypes of ionotropic glutamate receptor DiAntonio et al., 1999; Featherstone et al., 2005; Marrus et al., 2004; Qin et al., 2005; Schmid et al., 2008 ), which we call 'A-type' and 'B-type'. A-type receptors contain the subunits GluRIIA, GluRIIC/GluRIII, GluRIID, and GluRIIE. B-type receptors contain the subunits GluRIIB, GluRIIC/GluRIII, GluRIID, and GluRIIE. As shown in Fig. 6A , C, both A-and B-type receptors can be readily distinguished in larval and embryonic NMJs using antibodies specific for GluRIIA or GluRIIB. In CASK mutant larvae, total GluRIIA immunoreactivity was significantly reduced (by 24%; Fig. 6B ). GluRIIB immunoreactivity, however, was unchanged (Fig. 6B ). This alteration was present very early in development, as CASK mutant embryonic NMJs also showed significant loss of GluRIIA immunoreactivity without changes in GluRIIB (Fig. 6C-H) . Specifically, GluRIIA cluster size in embryonic CASK mutants was significantly reduced, while GluRIIB cluster size was unchanged (Fig. 6D ). In addition, there were fewer GluRIIA clusters per NMJ in embryonic CASK mutants (Fig. 6G) , while the number of GluRIIB clusters was unchanged (Fig. 6H ). This latter observation is consistent with the fact that A-and B-type receptors are segregated to different postsynaptic densities in embryonic (but not larval) NMJs .
To rule out the possibility that the reduction of postsynaptic GluRIIA in CASK mutants was secondary to a presynaptic defect, we expressed CASK RNAi presynaptically and postsynaptically, and measured GluRIIA immunoreactivity in larval NMJs (Fig. 7) . GluRIIA immunoreactivity was reduced only after expression of postsynaptic CASK RNAi, while expression of CASK RNAi presynaptically caused no change (Fig. 7B) .
The agreement between the CASK mutant phenotypes and tissuespecific expression of RNAi strongly argues that the synaptic alterations we describe are not due to background genetic effects. However, to further test this, and confirm that presynaptic loss of active zones is due to presynaptic loss of CASK, and postsynaptic loss of GluRIIA is due to loss of postsynaptic CASK, we utilized tissue-specific expression of a wildtype CASK transgene (Lu et al., 2003) in a homozygous CASK mutant background. The results of these experiments are shown in Fig. 8 . As expected if CASK is located both pre and postsynaptically at Drosophila NMJs, we could not rescue anti-CASK immunoreactivity to wildtype levels following either pre or postsynaptic expression of CASK alone (Fig. 8A, C) . Transgenic expression of wildtype CASK in presynaptic neurons but not postsynaptic muscles completely rescued immunoreactivity for the presynaptic active zone bruchpilot (Brp), as well as the overall number of active zones (Fig. 8D, E) . In contrast, transgenic expression of wildtype CASK in postsynaptic muscles but not presynaptic neurons completely rescued GluRIIA immunoreactivity (Fig. 8B, F) .
Discussion
Our results suggest that Drosophila CASK (CASK) plays important roles on both the presynaptic and postsynaptic sides of the embryonic/larval NMJ. Loss of presynaptic CASK reduces the number of synapses per NMJ, and (probably as a consequence of synapse loss) also reduces synaptic vesicle cycling, sEJC frequency, and evoked neurotransmitter release. Knockdown of postsynaptic CASK causes loss of A-type, but not B-type glutamate receptors, and also causes a reduction in sEJC amplitude and overall size of glutamate-gated currents. Confirming that the loss of glutamate receptors is due to postsynaptic CASK, the loss of A-type receptors is completely rescued by postsynaptic expression of a CASK transgene in an otherwise CASK null mutant background. These findings are consistent with previous studies but provide further details, including demonstration that CASK has cell autonomous pre and postsynaptic roles. Our data also show that embryonic NMJs have similar phenotypes as larval NMJs, suggesting that Drosophila CASK mutant phenotypes arise early in synapse formation, and are not due to changes during larval development.
The Drosophila CASK locus is believed to express two isoforms: A long isoform called 'CASK-beta', and a short isoform called 'CASKalpha' (Slawson et al., 2011) . CASK-beta is most similar to mammalian CASK, while CASK-alpha is more similar to vertebrate MPP1 (Slawson et al., 2011) . The deletion mutants and RNAi transgene we used for this study cause loss of both isoforms, and our antibody cannot distinguish between the CASK-alpha and CASK-beta. Therefore we cannot definitely attribute the phenotypes we describe to loss of a particular CASK isoform. However, the CASK transgene we used for Fig. 8 is CASK-beta (Slawson et al., 2011) , and expression of CASK-beta either presynaptically or postsynaptically rescued overall CASK immunoreactivity in NMJs to appropriate levels (Fig. 8A,C) .
Like us, Sun et al (2009) examined X-307/X-313 mutants for larval NMJ phenotypes. Like us, they observed that X-307/X-313 mutants have decreased FM1-43 staining and reduced synaptic transmission (Sun et al., 2009 ). However, in contrast to the reduced spontaneous synaptic event amplitude and frequency that we measured in both embryos and larvae, they measured an increase in larval mEJP amplitude and frequency (Sun et al., 2009) . We cannot explain the difference between their results and ours, except to note that the reduction in mini frequency and amplitude that we observed is consistent with our other results, whereas it is difficult to understand how the increases in mEJP amplitude and frequency that Sun et al measured could be associated with the decreased FM1-43 staining Fig. 5 . Synapse number and size in larval (A-C) and embryonic (D-E) muscle 6/7 NMJs. A: Representative images of larval ventral longitudinal muscle 6/7 NMJs, showing immunoreactivity for the neuronal membrane marker anti-HRP (green) and anti-bruchpilot (BRP) (blue), in control animals (top 3 panels) and CASK null mutants (bottom 3 panels). B: Representative images of anti-GluRIIC (red) and anti-bruchpilot (BRP) immunoreactivity in individual boutons from muscle 6/7 NMJs, in control animals (top 4 panels) and CASK null mutants (bottom 4 panels). C: Quantification of NMJ area (N = 9 for each genotype), bouton number per NMJ (N = 8-9), active zone number per NMJ (N = 9), total BRP immunoreactivity per NMJ (N = 19 for each genotype), active zone density (N = 8 for each genotype), number of active zones per bouton (N = 8 for each genotype), and total GluRIIC immunoreactivity (N = 21 for each genotype), in control and CASK null mutant larval muscle 6/7 NMJs. D: As in A, but showing muscle 6/7 NMJs in embryos. E: Quantification of NMJ area (N = 28 for each genotype), active zone number per NMJ (N = 10-11), active zone size (normalized to total NMJ size; N = 329-467), and active zone size (not normalized, as a cumulative frequency histogram), in control and CASK null mutant embryonic muscle 6/7 NMJs.
and EJP amplitude that they also reported. The increase in mEJP frequency that they measured is however consistent with the fact that they also measured a mild increase in the number of NMJ boutons in CASK mutants compared to WT, whereas we measured no change in bouton number or NMJ area. Note also that they counted approximately 100 boutons in WT third instar muscle 6/7 NMJs, whereas we counted approximately 60. Bouton numbers are very sensitive to various conditions, including larval locomotor activity, and therefore it's possible that Sun et al. raised their larvae under conditions which promote NMJ terminal growth, and these conditions reveal a mild role for CASK in NMJ morphological development.
The mechanisms by which CASK might regulate presynaptic function have been extensively discussed. CASK might regulate presynaptic function via its kinase or scaffolding activity (Hsueh, Fig. 6 . Glutamate receptor immunoreactivity in larval (A-B) and embryonic (C-H) muscle 6/7 NMJs. A: Representative images of larval ventral longitudinal muscle 6/7 NMJs, showing immunoreactivity for the neuronal membrane marker anti-HRP (green) and anti GluRIIA or GluRIIB (magenta), in control animals (top row of panels) and CASK null mutants (bottom row of panels). B: Total GluRIIA (top) and GluRIIB (bottom) immunoreactivity in control and CASK mutant larval 6/7 NMJs (N = 14 for each genotype). C: As in A, but embryonic NMJs. D: Cumulative frequency plots of GluRIIA (top) and GluRIIB (bottom) cluster sizes in control (black closed circles) and CASK mutant (open magenta circles) embryonic muscle 6/7 NMJs. E: GluRIIA cluster area in control and CASK mutant embryonic NMJs (N =188-311). F: GluRIIB cluster area in control and CASK mutant embryonic NMJs (N =229-254). G: GluRIIA cluster density in control and CASK mutant embryonic NMJs (N = 9 for each genotype). H: GluRIIB cluster density in control and CASK mutant embryonic NMJs (N =8-9).
2006; Mukherjee et al., 2008; Samuels et al., 2007) , or during trafficking of synaptic components to the presynaptic membrane (Fairless et al., 2008) .
But what about postsynaptic CASK? Our data demonstrate that CASK promotes subtype-specific glutamate receptor clustering. How does CASK promote subtype-specific glutamate receptor clustering? We hypothesize that CASK interacts with neurexin and 4.1 protein to regulate the membrane-associated actin cytoskeleton, which in turn controls subtype-specific glutamate receptor clustering. CASK, neurexin, and 4.1 protein are all present in Drosophila embryonic/larval NMJs Chen et al., 2010; Sun et al., 2009) . We have previously demonstrated that Drosophila 4.1 protein regulates the postsynaptic actin cytoskeleton and interacts directly with GluRIIA to regulate A-type but not B-type glutamate receptor clustering . We have also recently shown that neurexin is present postsynaptically in Drosophila NMJs and regulates A-type, but not B-type glutamate receptor clustering (Chen et al., 2010) . Thus, 4.1 protein, neurexin, and CASK are all present postsynaptically in Drosophila NMJs and all regulate A-type, but not B-type glutamate receptor clustering. Mammalian CASK has been shown to interact with 4.1 protein (Biederer and Sudhof, 2001; Chao et al., 2008; Cohen et al., 1998) , and a CASK/4.1/neurexin complex regulates F-actin assembly near neuronal membranes (Biederer and Sudhof, 2001) . Drosophila CASK/neurexin double heterozygotes also show changes in FM1-43 dye uptake and spontaneous synaptic transmission similar to that of homozygous CASK or neurexin mutants alone (Sun et al., 2009 ).
It's not clear precisely how regulation of the actin cytoskeleton by a CASK/neurexin/4.1 protein complex might direct A-type glutamate receptor clustering. The first evidence that actin might regulate Drosophila glutamate receptor clustering came from the finding that PAK (p21-activated kinase) affects A-type receptor cluster formation (Albin and Davis, 2004) . PAK is a regulator of the actin cytoskeleton (Hofmann et al., 2004) . We subsequently showed that A-type, but not B-type receptor cluster formation depended on the presence of postsynaptic actin filaments, by showing that GluRIIA (but not GluRIIB) clusters could be disrupted by introduction of actin depolymerizing agents cofilin and latrunculin to the interior of the postsynaptic muscle cell via patch pipette . Because these pharmacological effects were blocked in 4.1 protein mutants, and yeast two hybrid experiments showed that Drosophila 4.1 protein interacts directly with the C-terminus of GluRIIA, we concluded that GluRIIA was anchored via 4.1 protein to the postsynaptic actin cytoskeleton . However, it's possible that A-type receptors are merely trafficked via GluRIIA/4.1 protein to the postsynaptic density via the actin cytoskeleton, using myosin Vb as a motor (Wang et al., 2008) , and not actually anchored to the actin cytoskeleton in postsynaptic densities. This finding is consistent with the fact that no direct interaction has ever been found between coracle (Drosophila 4.1) and actin, and the fact that we previously recovered Myosin Vb in a screen for genes regulating GluRIIA cluster development .
Previous studies have focused mostly on presynaptic roles for neurexin, CASK, and 4.1 protein. Our results and the postsynaptic model described above do not conflict with these studies. They merely add an extra postsynaptic facet to these fascinating synaptic proteins.
Experimental methods

Genetics
The Drosophila genome encodes a single CASK homolog (CG6703), originally described in print as 'caki' (Martin and Ollo, 1996) , but since then by various other names including 'Camguk', 'CMG', 'DLin-2', and 'CASK'. In response to community request, the official name for the gene in Flybase was recently changed to CASK. We here therefore refer Fig. 7 . GluRIIA immunoreactivity in larval NMJs after pre or postsynaptic expression of CASK RNAi. A: Representative images of ventral longitudinal muscle 6/7 NMJs, showing immunoreactivity for the neuronal membrane marker anti-HRP (green) and anti GluRIIA (blue), in control larvae (left row of panels), larvae expressing postsynaptic CASK RNAi (middle row of panels), and larvae expressing presynaptic CASK RNAi (right row of panels). B: GluRIIA in control and CASK RNAi-expressing larval 6/7 NMJs, quantified (N = 4-7).
to the gene and its product(s) as 'CASK'. The Drosophila CASK mutants used in our study are a transheterozygous combination of two X-ray induced deletions in the Drosophila CASK gene. These deletions are 'X-307' and 'X-313'. X-307/X-313 was originally referred to as caki 1 , or caki[X-307]/caki [X-313] (Martin and Ollo, 1996) . However, to stay consistent with the recent nomenclature changes, and preclude confusion that might be caused by future unexpected name changes, we here refer to these mutants as 'X-307/X-313'. X-307/X-313 mutants delete both CASK-alpha and CASK-beta (Slawson et al., 2011) and eliminate all CASK immunoreactivity in the adult brain (Martin and Ollo, 1996) , larval neuropil, and larval body wall muscles (Lu et al., 2003) .
Tissue-specific expression of transgenes was performed using the Gal4/UAS system (Brand et al., 1994) . Neuron-specific expression was driven using the 'C155 Elav' Gal4 driver: P{GawB}elav[C155]. Musclespecific expression was driven using the '24B' Gal4 driver: P{GawB}how [24B] or 'G14' Gal4 driver: P{Gal4}G14. The UAS-CASK RNAi transgene that we used is Vienna Drosophila RNAi Center (VDRC) transformant #34184 (3rd chromosome). This RNAi is predicted to target all CASK isoforms. Control strains were Oregon R or w [1118] . We have noted no statistically significant difference between w[1118] and Oregon R for any of the parameters measured. We nonetheless used w[1118] as a control where the test genotype contains the w[1118] mutation, and Oregon R when the test genotype does not. Specifically, w[1118] was present in all lines containing transgenes, and therefore w[1118] was used as a control for these experiments. Although not explicitly described or shown in figures, C155 ElavGal4/+, 24B Gal4/+, G14 Gal4/ +, UAS-CASK/+, and UAS-CASK RNAi/+ were also statistically indistinguishable from Oregon R or w [1118] with regard to the glutamate receptor phenotypes described here.
UAS-CASK (uas-cmg) flies (Lu et al., 2003) were a gift from Leslie Griffith.
Immunohistochemistry and confocal microscopy
For immunohistochemistry and confocal microscopy, animals were manually dissected and fixed in Bouin's fixative as previously described . CASK polyclonal antibodies were raised in rabbits against the synthetic CASK-specific peptide SIFGRKKKQCRDKYLAKH and affinity purified by Open Biosystems (Huntsville AL). This epitope lies in the C-terminal end of CASK and is 100% conserved between CASK-alpha and CASK-beta. Our antibody therefore does not distinguish between the isoforms. Anti-CASK antibodies were used at 1:2000 in wandering third instar larval NMJs and 1:1000 in late stage embryos (22-24 h after egg laying (AEL) at 25 C, temporally and morphologically staged). Mouse monoclonal anti-GluRIIA (8B4D2), from a cell line made by Christoph Schuster and available from University of Iowa's Developmental Studies Hybridoma Bank (DSHB), was used at 1:100 (Featherstone et al., 2002) . Rabbit polyclonal anti-GluRIIB and rabbit polyclonal anti-GluRIIC, first described in Marrus et al. (2004) and subsequently replicated in the Featherstone lab, were used at 1:2000 (Marrus et al., 2004) . Antibruchpilot/Brp (NC82), originally a gift from Eric Buchner but now also available from DSHB, was used at 1:100 . Fluorescently-conjugated anti-HRP (Jackson Immuno laboratories, West Grove PA) was used at 1:200. Immunoreactivity was visualized using FITC-, TRITC-, or CY5-conjugated goat anti-mouse/rabbit secondary antibodies (Jackson Immuno Laboratories), used at 1:400-1:2000. All images of NMJs are from ventral longitudinal muscles 6 and 7 in abdominal segments 3-4. Control and experimental preparations were always stained and imaged in parallel.
Images were captured using an Olympus Fluoview FV500 laser scanning confocal system. Quantification of staining intensity was performed as previously described (Featherstone et al., 2001) . Briefly, fluorescence intensity of relevant structures from unaltered unsaturated confocal maximum intensity projections was measured by manually selecting the region of interest in imageJ and measuring mean pixel intensity of that region. To control for differences in individual preparation immunoreactivity, excitation efficiency, fluorescence attenuation, and fluorescence detection, we then subtracted mean pixel intensity of a similarly-sized region of unstained 'background' in the same fluorescence wavelength channel in the same image.
For immunohistochemical measurement of active zone and glutamate receptor cluster size, ImageJ software was used to manually outline every puncta visible on a 6/7 NMJ, as previously described Featherstone et al., 2002) . We then used ImageJ to convert puncta area (in pixels) to square micrometers based on pixel size values computed for each image by Fluoview confocal software, which automatically records image resolution, microscope objective, and 'zoom' factor in each image file. Muscle 6/7 NMJ sizes were measured in a similar fashion, using synaptic anti-HRP fluorescence.
All measurements were from raw unaltered image files. After measurements were taken, Adobe Photoshop was used to crop images and adjust contrast for final display.
Electrophysiology
In both larvae (~120 h After Egg Laying; AEL) and embryos (22-24 h AEL) ventral longitudinal muscle 6 was whole-cell voltage clamped at −60 mV in bath solution containing standard Drosophila saline (135 mM NaCl, 5 mM KCl, 4 mM MgCl 2 , 1.8 mM CaCl 2 , 72 mM sucrose, and 5 TES, pH 7.2). Larval muscle 6 is too large and electrically leaky for voltage clamp using patch pipettes, and therefore twoelectrode voltage clamp was used, as previously described (Chen et al., 2008) . Embryonic muscle 6, on the other hand, is too small for two electrode voltage clamp and yet cannot be adequately space clamped with a single sharp electrode, so patch-clamp electrophysiology was used, as previously described Featherstone et al., 2000) . The patch pipette solution contained: 120 mM KCl, 20 mM KOH, 4 mM MgCl 2 , 0.25 mM CaCl 2 , 5 mM EGTA, 36 mM sucrose, and 5 mM TES.
Evoked synaptic currents in both larvae and embryos were triggered by 5-10 V electrical stimulation of the appropriate segmental nerve using a suction electrode filled with bath solution. Glutamate-gated currents in embryonic NMJs were evoked by pressure ejection of 1 mM glutamate onto NMJs using small glass pipettes and a picospritzer II, as previously described (Featherstone et al., 2001 ).
FM1-43 experiments
Larvae were prepared as for electrophysiology (see above), except dissections were performed in 0 mM Ca 2+ Drosophila saline, and muscle 6/7 NMJs were imaged using a 63× water immersion objective and Olympus Fluoview FV500 confocal microscope. Terminals were loaded with FM1-43 by bathing dissected preparations for 5 min in high potassium Drosophila saline containing 10 μm FM1-43 (135 mM NaCl, 90 mM KCl, 4 mM MgCl 2 , 1.8 mM CaCl 2 , 72 mM sucrose, 5 TES, Fig. 8 . Rescue of larval NMJ phenotypes after tissue-specific expression of a CASK transgene. A: Representative images of ventral longitudinal muscle 6/7 NMJs in third instar larvae, showing immunoreactivity for the neuronal membrane marker anti-HRP (magenta) and anti-CASK (green), in control larvae (top row of panels), CASK null mutant (X-307/X-313) larvae expressing a wildtype CASK transgene in presynaptic neurons (middle row of panels), and CASK null mutant (X-307/X-313) larvae expressing a wildtype CASK transgene in postsynaptic muscles (bottom row of panels). B: Representative images of ventral longitudinal muscle 6/7 NMJs in third instar larvae, showing immunoreactivity for the neuronal membrane marker anti-HRP (magenta) and anti-GluRIIA (green), in control larvae (top row of panels), CASK null mutant larvae expressing a wildtype CASK transgene in presynaptic neurons (middle row of panels), and CASK null mutant larvae expressing a wildtype CASK transgene in postsynaptic muscles (bottom row of panels). C: CASK immunoreactivity measured in NMJs of CASK null mutant larvae expressing a wildtype CASK transgene in either presynaptic neurons (Elav;UAS.CASK;X307/X313 or postsynaptic muscles (Elav;UAS. CASK;X307/X313). D: Immunoreactivity of the active zone protein Bruchpilot (Brp), measured in NMJs of CASK null mutant larvae (X-307/X-313), or CASK null mutant larvae expressing a wildtype CASK transgene specifically in presynaptic neurons (Elav;UAS.CASK;X307/X313). E: Number of active zones (visualized using anti-Brp immunoreactivity), measured in NMJs of CASK null mutant larvae (X307/X313), or CASK null mutant larvae expressing a wildtype CASK transgene specifically in presynaptic neurons (Elav;UAS.CASK; X307/X313). F: GluRIIA immunoreactivity measured in NMJs of CASK null mutant larvae expressing a wildtype CASK transgene in either presynaptic neurons (Elav;UAS.CASK;X307/ X313) or postsynaptic muscles (Elav;UAS.CASK;X307/X313).
and 10 μm FM1-43; pH 7.2), then washed with 0 mM Ca 2+ Drosophila saline 6-8 times over 5 min before imaging. Unloading was induced by bathing preparations in high potassium Drosophila saline without FM1-43. As for loading, preparations were then rinsed in 0 mM Ca
2+
Drosophila saline before being imaged.
Statistics
Statistical significance was determined using unpaired Student t-tests (for normally distributed data) or nonparametric Mann Whitney tests (when post-hoc F-tests determined that variances were significantly different). Distributions were compared using a KolmogorovSmirnov test. Asterisks in figures indicate statistical significance: *** = p b 0.0001, **= p b 0.001, * = p b 0.05.
